Short Interest in Biofrontera Inc. (NASDAQ:BFRIW) Declines By 33.2%

Biofrontera Inc. (NASDAQ:BFRIW) was the target of a large decrease in short interest in January. As of January 15th, there was short interest totaling 3,504 shares, a decrease of 33.2% from the December 31st total of 5,247 shares. Based on an average daily trading volume, of 881 shares, the days-to-cover ratio is presently 4.0 days. Based on an average daily trading volume, of 881 shares, the days-to-cover ratio is presently 4.0 days.

Biofrontera Price Performance

NASDAQ BFRIW traded up $0.00 on Friday, reaching $0.05. The company’s stock had a trading volume of 100 shares, compared to its average volume of 1,867. Biofrontera has a twelve month low of $0.03 and a twelve month high of $0.28. The firm’s 50 day moving average is $0.06 and its two-hundred day moving average is $0.10.

About Biofrontera

Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.

The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.